5085 related articles for article (PubMed ID: 3652030)
1. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
Schallreuter KU; Wood JM
Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
[TBL] [Abstract][Full Text] [Related]
2. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid.
Schallreuter KU; Wood JM
Biochem Biophys Res Commun; 1989 Apr; 160(2):573-9. PubMed ID: 2719682
[TBL] [Abstract][Full Text] [Related]
3. A possible mechanism of action for azelaic acid in the human epidermis.
Schallreuter KU; Wood JW
Arch Dermatol Res; 1990; 282(3):168-71. PubMed ID: 2114832
[TBL] [Abstract][Full Text] [Related]
4. The role of calcium in the regulation of free radical reduction by thioredoxin reductase at the surface of the skin.
Schallreuter KU; Pittelkow MR; Gleason FK; Wood JM
J Inorg Biochem; 1986; 28(2-3):227-38. PubMed ID: 2433392
[TBL] [Abstract][Full Text] [Related]
5. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
Schallreuter KU; Pittelkow MR
Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase.
Schallreuter KU; Gleason FK; Wood JM
Biochim Biophys Acta; 1990 Aug; 1054(1):14-20. PubMed ID: 2200526
[TBL] [Abstract][Full Text] [Related]
7. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and a human melanoma cell line in tissue culture.
Robins EJ; Breathnach AS; Bennett D; Ward BJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Br J Dermatol; 1985 Dec; 113(6):687-97. PubMed ID: 4096883
[TBL] [Abstract][Full Text] [Related]
10. Effect of dicarboxylic acids on Harding-Passey and Cloudman S91 melanoma cells in tissue culture.
Robins EJ; Breathnach AS; Ward BJ; Bhasin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
J Invest Dermatol; 1985 Sep; 85(3):216-21. PubMed ID: 4031537
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thioredoxin reductase (E.C. 1.6.4.5.) by antitumor quinones.
Mau BL; Powis G
Free Radic Res Commun; 1990; 8(4-6):365-72. PubMed ID: 2162313
[TBL] [Abstract][Full Text] [Related]
12. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture.
Breathnach AS; Robins EJ; Pätzold HC; Bhasin YP; Ethridge LB; Garner A; Nazzaro-Porro M
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):491-8. PubMed ID: 2925320
[TBL] [Abstract][Full Text] [Related]
13. The activity and purification of membrane-associated thioredoxin reductase from human metastatic melanotic melanoma.
Schallreuter KU; Wood JM
Biochim Biophys Acta; 1988 Oct; 967(1):103-9. PubMed ID: 2844280
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
[No Abstract] [Full Text] [Related]
16. [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures].
Geier G; Hauschild T; Bauer R; Kreysel HW
Hautarzt; 1986 Mar; 37(3):146-8. PubMed ID: 3700102
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine.
Schallreuter KU; Wood JM
Biochim Biophys Acta; 1991 Jun; 1096(4):277-83. PubMed ID: 2065101
[TBL] [Abstract][Full Text] [Related]
18. Scanning electron microscopy of human and murine melanoma cells exposed to medium chain-length (C6-C12) dicarboxylic acids in tissue culture.
Breathnach AS; Robins EJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1987 Jul; 2(3):291-7. PubMed ID: 2980732
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
Stamatiadis D; Bulteau-Portois MC; Mowszowicz I
Br J Dermatol; 1988 Nov; 119(5):627-32. PubMed ID: 3207614
[TBL] [Abstract][Full Text] [Related]
20. Effect of L-carnitine on cultured murine melanoma cells exposed to azelaic acid.
Ward BJ; Breathnach AS; Robins EJ; Bhasin YP; Ethridge L; Nazzaro-Porro M; Passi S
J Invest Dermatol; 1986 Apr; 86(4):438-41. PubMed ID: 3745962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
